1,3-Dipolar Cycloaddition of Nitrile Imines
by column chromatography using a 20–30% mixture of EtOAc/
hexane as the eluent.
(m, 5 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 23.4, 23.6, 39.0,
52.9, 119.0, 124.6 (2 C), 129.3, 129.7 (2 C), 138.2, 142.6, 151.0,
162.3, 191.1 ppm. IR (CCl ): ν = 2954, 1724, 1697, 1548, 1496,
˜
4
Methyl 6-Oxo-1-phenyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-
carboxylate (5a): M.p. 176–177 °C. Yellow solid. 1H NMR
(400 MHz, CDCl3): δ = 3.10–3.21 (m, 4 H), 3.99 (s, 3 H), 7.33–
7.41 (t, J = 6 Hz, 1 H), 7.44–7.53 (t, J = 6 Hz, 2 H), 8.08–8.14 (d,
J = 6 Hz, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 19.1, 43.8,
52.5, 121.0 (2 C), 128.4, 129.5 (2 C), 138.4, 138.8, 144.9, 151.5,
1253, 1202, 1132, 993, 810 cm–1.
Methyl 1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-indazole-
3-carboxylate (6b) and Methyl 1-(4-Methoxyphenyl)-4-oxo-4,5,6,7-
tetrahydro-1H-indazole-3-carboxylate (6bЈ): Compounds 6b and 6bЈ
were obtained as solids following the general procedure for 1,3-DC
followed by oxidation with CAN. The two products were separated
by column chromatography using a 10–30% mixture of EtOAc/
hexane as the eluent.
162.0, 188.0 ppm. IR (CCl ): ν = 2955, 2361, 1720, 1592, 1547,
˜
4
1502, 1254, 1126, 1011, 823 cm–1.
Methyl 4-Oxo-1-phenyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-
carboxylate (5aЈ): M.p. 155–156 °C. Yellow solid. 1H NMR
(300 MHz, CDCl3): δ = 3.15–3.29 (m, 4 H), 4.00 (s, 3 H), 7.39–
7.46 (t, J = 7.5 Hz, 1 H), 7.48–7.56 (t, J = 7.5 Hz, 2 H), 7.69–7.74
(d, J = 6 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 22.0,
43.5, 52.9, 121.0 (2 C), 128.4, 128.6, 129.9 (2 C), 138.4, 138.6, 161.3,
Methyl 1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-indazole-
3-carboxylate (6b): M.p. 144–145 °C. Brown solid. 1H NMR
(300 MHz, CDCl3): δ = 2.14–2.25 (quint., J = 6 Hz, 2 H), 2.55–
2.63 (t, J = 6 Hz, 2 H), 3.10–3.17 (t, J = 6 Hz, 2 H), 3.85 (s, 3 H),
3.96 (s, 3 H), 6.91–6.97 (d, J = 6 Hz, 2 H), 7.38–7.43 (d, J = 6 Hz,
2 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 22.1, 24.3, 39.8, 52.2,
55.7, 113.8 (2 C), 127.0 (2 C), 132.8, 134.5, 136.3, 139.9, 160.1,
165.3 191.4 ppm. IR (CCl ): ν = 2955, 2361, 1720, 1592, 1547,
˜
4
1502, 1254, 1126, 1011, 823 cm–1.
162.6, 188.0 ppm. IR (CCl ): ν = 2954, 1723, 1696, 1548, 1516,
˜
4
Methyl 1-(4-Methoxyphenyl)-6-oxo-1,4,5,6-tetrahydrocyclopenta[c]-
pyrazole-3-carboxylate (5b) and Methyl 1-(4-Methoxyphenyl)-4-oxo-
1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carboxylate (5bЈ): Com-
pounds 5b and 5bЈ were obtained as solids following the general
procedure for 1,3-DC followed by oxidation with CAN. The two
products were separated by column chromatography using a 20–
30% mixture of EtOAc/hexane as the eluent.
1252, 1203, 1133, 1038, 988 cm–1.
Methyl 1-(4-methoxyphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-indazole-
3-carboxylate (6bЈ): M.p. 127–128 °C. Brown solid. 1H NMR
(300 MHz, CDCl3): δ = 2.10–2.21 (quint., J = 6 Hz, 2 H), 2.55–
2.62 (t, J = 6 Hz, 2 H), 2.85–2.92 (t, J = 6 Hz, 2 H), 3.86 (s, 3 H),
3.97 (s, 3 H), 6.97–7.02 (d, J = 9 Hz, 2 H), 7.37–7.43 (d, J = 9 Hz,
2 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 23.4 (2 C), 39.0, 52.8,
55.8, 114.7 (2 C), 118.8, 126.1 (2 C), 131.1, 142.2, 151.0, 160.2,
Methyl 1-(4-Methoxyphenyl)-6-oxo-1,4,5,6-tetrahydrocyclopenta[c]-
pyrazole-3-carboxylate (5b): M.p. 174–175 °C. Yellow solid. 1H
NMR (300 MHz, CDCl3): δ = 3.06–3.21 (m, 4 H), 3.84 (s, 3 H),
3.97 (s, 3 H), 6.92–7.02 (d, J = 9 Hz, 2 H), 7.96–8.05 (d, J = 9 Hz,
2 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 19.1, 43.8, 52.6, 55.7,
114.5 (2 C), 122.5 (2 C), 132.3, 137.9, 144.5, 151.0, 159.8, 162.1,
162.3, 191.1 ppm. IR (CCl ): ν = 2954, 1723, 1696, 1548, 1516,
˜
4
1252, 1203, 1133, 1038, 988 cm–1.
Methyl 8-Oxo-1-phenyl-1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-
3-carboxylate (7a) and Methyl 4-Oxo-1-phenyl-1,4,5,6,7,8-hexahy-
drocyclohepta[c]pyrazole-3-carboxylate (7aЈ): Compounds 7a and
7aЈ were obtained as solids following the general procedure for 1,3-
DC followed by oxidation with CAN. The two products were sepa-
rated by column chromatography using a 10–30% mixture of
EtOAc/hexane as the eluent.
189.2 ppm. IR (CCl ): ν = 2920, 1677, 1590, 1422, 1323, 1291,
˜
4
1277, 1181, 1010, 934 cm–1.
Methyl 1-(4-Methoxyphenyl)-4-oxo-1,4,5,6-tetrahydrocyclopenta[c]-
pyrazole-3-carboxylate (5bЈ): M.p. 165–166 °C. Brown solid. 1H
NMR (300 MHz, CDCl3): δ = 3.15–3.20 (m, 4 H), 3.86 (s, 3 H),
4.00 (s, 3 H), 6.98–7.04 (d, J = 9 Hz, 2 H), 7.57–7.63 (d, J = 9 Hz,
2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 21.7, 43.5, 52.9, 55.8,
115.0 (2 C), 122.8 (2 C), 128.0, 131.8, 138.0, 159.7, 161.5, 165.0,
Methyl 8-Oxo-1-phenyl-1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-
3-carboxylate (7a): M.p. 205–206 °C. White solid. 1H NMR
(300 MHz, CDCl3): δ = 1.83–1.98 (m, 4 H), 2.67–2.78 (t, J = 6 Hz,
2 H), 3.19–3.29 (t, J = 6 Hz, 2 H), 3.89 (s, 3 H), 7.28–7.42 (m, 5
H) ppm. 13C NMR (75 MHz, CDCl3): δ = 22.1, 23.3, 25.7, 43.1,
52.2, 126.0 (2 C), 128.9 (2 C), 129.0, 131.0, 140.4, 140.6, 140.6,
191.4 ppm. IR (CCl ): ν = 2920, 1677, 1590, 1422, 1323, 1291,
˜
4
1277, 1181, 1010, 934 cm–1.
Methyl 7-Oxo-1-phenyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxyl-
ate (6a) and Methyl 4-Oxo-1-phenyl-4,5,6,7-tetrahydro-1H-indazole-
3-carboxylate (6aЈ): Compounds 6a and 6aЈ were obtained as solids
following the general procedure for 1,3-DC followed by oxidation
with CAN. The two products were separated by column
chromatography using a 10–30% mixture of EtOAc/hexane as the
eluent.
163.0, 192.7 ppm. IR (CCl ): ν = 2905, 1722, 1686, 1588, 1548,
˜
4
1320, 1179, 1012 cm–1.
Methyl 4-Oxo-1-phenyl-1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-
3-carboxylate (7aЈ): M.p. 166–167 °C. Yellow solid. 1H NMR
(400 MHz, CDCl3): δ = 1.91–2.03 (m, 4 H), 2.79–2.85 (t, J = 6 Hz,
2 H), 2.88–2.94 (t, J = 6 Hz, 2 H), 3.95 (s, 3 H), 7.39–7.44 (m, 2
H), 7.46–7.55 (m, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
1.88–2.03 (m, 4 H), 2.77–2.85 (t, J = 6 Hz, 2 H), 2.86–2.94 (t, J =
6 Hz, 2 H), 3.93 (s, 3 H), 7.37–7.44 (m, 2 H), 7.45–7.55 (m, 3 H)
Methyl 7-Oxo-1-phenyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxyl-
ate (6a): M.p. 199–200 °C. Yellow solid. 1H NMR (400 MHz,
CDCl3): δ = 2.09–2.18 (quint., J = 6 Hz, 2 H), 2.50–2.57 (t, J =
6 Hz, 2 H), 3.05–3.11 (t, J = 6 Hz, 2 H), 3.90 (s, 3 H), 7.36–7.47
(m, 5 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 22.1, 24.3, 39.8,
52.3, 125.8 (2 C), 128.8 (2 C),129.7, 134.8, 136.4, 139.7, 140.3,
ppm. IR (CCl ): ν = 2905, 1722, 1686, 1588, 1548, 1320, 1179,
˜
4
1012 cm–1.
Methyl
1-(4-Methoxyphenyl)-8-oxo-1,4,5,6,7,8-hexahydrocyclo-
hepta[c]pyrazole-3-carboxylate (7b) and Methyl 1-(4-Methoxy-
phenyl)-4-oxo-1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carb-
oxylate (7bЈ): Compounds 7b and 7bЈ were obtained as solids fol-
lowing the general procedure for 1,3-DC followed by oxidation
with CAN. The two products were separated by column
chromatography using a 10–30% mixture of EtOAc/hexane as the
162.7, 188.0 ppm. IR (CCl ): ν = 2954, 1724, 1697, 1548, 1496,
˜
4
1253, 1202, 1132, 993, 810 cm–1.
Methyl 4-Oxo-1-phenyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxyl-
ate (6aЈ): M.p. 100–101 °C. Brown solid. 1H NMR (300 MHz,
CDCl3): δ = 2.12–2.22 (quint., J = 6 Hz, 2 H), 2.56–2.65 (t, J =
6 Hz, 2 H), 2.91–2.99 (t, J = 6 Hz, 2 H), 3.98 (s, 3 H), 7.45–7.54 eluent.
Eur. J. Org. Chem. 2011, 4806–4813
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4811